Herpes Simplex Virus Infection Treatments Market: Rise in prevalence of HSV infection to drive the market

Herpes Simplex Virus Infection Treatments Market: Introduction

  • Herpes simplex virus infection is commonly known as herpes. The two types of herpes simplex virus (HSV) are HSV-1 (known to cause orofacial disease such as cold sores) and HSV-2 (causes genital infections). Over 80% of herpes infections are asymptomatic. Symptomatic infections are presented with blistering sores, pain during urination, swollen lymph nodes, and fever. The period of latency and mode of reactivation of HSV is still unclear.

Read Report Overview - https://www.transparencymarketresearch.com/herpes-simplex-virus-infection-treatments-market.html

  • According to prevalence statistics published by the Centers for Disease Control and Prevention (CDC), HSV-2 prevalence was over 16% among the population of the U.S. and primarily affected African-American women. The Public Health Agency of Canada indicated that prevalence of HSV-1 infection is greater than HSV-2 infections in most of regions. Various publications also show that prevalence of HSV is higher in low and middle income countries. Hence, prevalence of herpes simplex virus is expected to be high in countries in Africa. Demand for cost-effective diagnostic tests is high due to underdeveloped economic conditions.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=58977

Key Drivers, Restraints, and Opportunities of Global Herpes Simplex Virus Infection Treatments Market

  • Rise in prevalence of HSV infection, increase in rate of new infections, and continuous mutations in the microorganisms leading to new strains are key factors driving the global herpes simplex virus infection treatments market. Furthermore, increase in modes of transmission of the infectious disease and lack of cleanliness in developing regions are further fueling the herpes simplex virus infection treatments market. According to the WHO, more women are infected with HSV-2 than men. In 2012, an estimated 267 million women and 150 million men were living with the infection.

Request for Analysis of COVID-19 Impact on Herpes Simplex Virus Infection Treatments Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=58977


  • Rise in burden of HSV encephalitis is anticipated to propel the market in this particular segment. As per the National Organizations for Rare Disorders, the prevalence of acute encephalitis in the U.S. is around 2,000 cases per year, and it includes around 10% of total cases of encephalitis occurring in the U.S.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=58977

North America to Capture Major Share of Global Herpes Simplex Virus Infection Treatments Market

In terms of region, the global herpes simplex virus infection treatments market can be segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is anticipated to dominate the global genital herpes market due to a rise in cases of infections of herpes simplex virus. As per the American Sexual Health Association, around 50% of the population in the U.S. suffers from oral herpes that is caused by HSV-1. Furthermore, approximately one in eight people is likely to suffer from HSV-2 infection. Moreover, as per the National Institutes of Health, by the age of 50, approximately 90% of people in the U.S. are exposed to this virus. Hence, this fuels the need for treatment of herpes and subsequently, propels the herpes simplex virus treatment market.

Pre Book Herpes Simplex Virus Infection Treatments Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=58977&ltype=S

Key Players Operating in Global Herpes Simplex Virus Infection Treatments Market

Key players operating in the global herpes simplex virus infection treatments market are GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Agenus, Inc., Maruho Co. Ltd., Sanofi Pasteur SA., Chimerix, Admedus, and AiCuris Anti-infective Cures GmbH.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

Back to news